Event: China Market Access Conference

Date: October 3, 2012

Venue: TBD, Paris, France

Weblink: www.lifescience-outlook.com/chinamarketaccess2012

Tel: + 86 21 2215 7611

Email: simon.pico@universalmedica.cn

 

In the past years, the global pharmaceutical industry has been experiencing a shift in its development: a geographic swing away from the major mature markets, to a set of new dynamic "pharmerging" countries. The Chinese and Russian pharmaceutical markets are part of these dynamic and rapidly developing markets. The Emerging Market Access conference held October 3^rd 2012 in Paris will bring insight to decision leaders for business opportunities and development in Russia and China.

An expected growth at 20% to 25% over the next decade in China makes it a very attractive market for pharmaceutical and bio­tech companies. With its large population, low costs, and a fast-growing economy with an expanding middle class with healthcare coverage and good infrastructure market, China is attracting many pharmaceutical and bio­tech companies. However, China presents many challenges for set­ting up clinical trials and performing biopharmaceutical development and has the longest drug application timeline of all Asian countries. Therefore, it is crucial to understand the system and define the best market access entry strategy.